Ali Faraz: insider trades.
Ali Faraz reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($16K), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- Ali Faraz
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Tenaya Therapeutics, Inc. (TNYA) | Director, Officer · Chief Executive Officer | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-10 | Tenaya Therapeutics, Inc. | A | 122,000 | $0 | 539,782 | Form 4 |
| 2026-08-17 | Tenaya Therapeutics, Inc. | S | 5,020 | $0.71 | 425,188 | Form 4 |
| 2026-08-17 | Tenaya Therapeutics, Inc. | S | 7,406 | $0.71 | 417,782 | Form 4 |
| 2026-08-17 | Tenaya Therapeutics, Inc. | S | 5,837 | $0.71 | 434,177 | Form 4 |
| 2026-08-17 | Tenaya Therapeutics, Inc. | S | 3,969 | $0.71 | 430,208 | Form 4 |
Questions
What stock did Ali Faraz buy or sell?
Ali Faraz reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($16K), across 1 company.
Is Ali Faraz the same person as other filers with this name?
This page covers SEC CIK 1667937 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/ali-faraz-1667937.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.